Results 141 to 150 of about 74,496 (193)

Patient-reported Effects of Fedratinib, an Oral, Selective Inhibitor of Janus Kinase 2, on Myelofibrosis-related Symptoms and Health-related Quality of Life in the Randomized, Placebo-controlled, Phase III JAKARTA Trial. [PDF]

open access: yesHemasphere, 2021
Mesa RA   +14 more
europepmc   +1 more source

Serum amyloid A and Janus kinase 2 in a mouse model of diabetic kidney disease. [PDF]

open access: yesPLoS One, 2019
Dieter BP   +9 more
europepmc   +1 more source

Molecular analysis of V617F mutation in Janus kinase 2 gene of breast cancer patients. [PDF]

open access: yesSaudi J Biol Sci, 2019
Karim S   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy